1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Waldenstroms Macroglobulinemia: new trials by email Literature Review of Waldenstroms Macroglobulinemia trials Research Report on Waldenstroms Macroglobulinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia Bortezomib, Dexamethasone, Rituximab - Waldenstroms Macroglobulinemia | Phase 2 | Completed | European Myeloma Network B.V. | 59 | 2006-09-01 | 2015-02-18 |
Waldenstrom Macroglobulinemia (1)
Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1) · Vascular Diseases (1)
Bortezomib (1) · Dexamethasone (1) · Rituximab (1)
European Myeloma Network B.V. (1)
Greece (1)